EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT OF CONSECUTIVE NON-SELECTED GLIOBLASTOMA PATIENTS RECEIVING STANDARD THERAPY

Glioblastoma is treated by standard with maximal surgical resection followed by radiation therapy with concomitant and adjuvant temozolomide. Still, median overall survival (OS) for glioblastoma is around 15 months, although the prognosis varies greatly. To improve the treatment, stratification of g...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Regner Michaelsen, Signe, Urup, Thomas, Grunnet, Kirsten, Jarle Christensen, Ib, Lassen, Ulrik, Skovgaard Poulsen, Hans
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Epidemiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847771/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.313
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia